Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease

NCT01355120

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations
  • Universitätsklinikum Erlangen Hautklinik Erlangen, Bavaria, Germany
  • Klinikum Nürnberg Nord Nuremberg, Bavaria, Germany
  • Klinikum Kassel GmbH Kassel, Hesse, Germany
  • Klinikum Dorothea Christiane Erxleben Quedlinburg gGmbH Quedlinburg, Saxony-Anhalt, Germany
View all 25 locations
View Trial Details
Completed

Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

NCT02902029

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Hôpital Ambroise-Paré Boulogne-Billancourt, France
  • Hospital Claude Huriez Lille, France
  • Hôpital de la Timone Marseille, France
  • CHU de Nantes Nantes, France
View all 27 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

NCT03635983

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0187 Tucson, Arizona, United States
  • Local Institution - 0014 La Jolla, California, United States
  • Local Institution - 0122 Stanford, California, United States
  • Local Institution - 0051 Aurora, Colorado, United States
View all 167 locations
View Trial Details
Completed

Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

NCT02437136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Maryland, Marlene and Stewart Greenbaum Cancer Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions